An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
908 Devices to Participate in Upcoming Investor Conferences
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
908 Devices Inc. (Nasdaq: MASS) will participate in investor conferences including the 53rd Annual Baird Industrial Conference, Stifel Healthcare Conference 2023, and 25th Annual Stephens Investment Conference. The conferences will feature in-person presentations and fireside chats. Interested parties can access live and archived webcasts on the company website.
Positive
None.
Negative
None.
BOSTON--(BUSINESS WIRE)--
908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, today announced it will participate in the following investor conferences.
53rd Annual Baird Industrial Conference
In-person presentation only on Wednesday, November 8th at 10:35 a.m. Pacific Time / 1:35 a.m. Eastern Time
Stifel Healthcare Conference 2023
Fireside chat on Tuesday, November 14th at 5 a.m. Pacific Time / 8 a.m. Eastern Time
25th Annual Stephens Investment Conference
Fireside chat on Wednesday, November 15 at 6 a.m. Pacific Time / 9 a.m. Eastern Time
Interested parties may access a live and archived webcast of these sessions on the “Investors” section of the company website at: www.908devices.com.
About 908 Devices
908 Devices is revolutionizing chemical and biochemical analysis with its simple handheld and desktop devices, addressing critical-to-life applications. The Company’s devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the most critical problems in life sciences research, bioprocessing, pharma/biopharma, forensics and adjacent markets. The Company is headquartered in the heart of Boston, where it designs and manufactures innovative products that bring together the power of mass spectrometry, microfluidic sampling and separations, software automation, and machine learning.
908 Devices Inc. is participating in investor conferences.
What are the names of the conferences?
The conferences include the 53rd Annual Baird Industrial Conference, Stifel Healthcare Conference 2023, and 25th Annual Stephens Investment Conference.
What type of presentations will be held?
There will be in-person presentations and fireside chats.
Where can interested parties access the webcasts?
Interested parties can access the live and archived webcasts on the 'Investors' section of the company website at www.908devices.com.
908 devices, is democratizing chemical analysis by way of mass spectrometry, offering point-of-need chemical analysis devices ranging from rugged, handheld chemical detection tools to compact, tiny footprint analyzers and fast separation devices. these purpose-built and user-centric devices serve a range of industries including safety and security, oil & gas, life sciences and other applied markets. 908 devices is headquartered in the heart of boston where they research, design and manufacture innovative products based on high pressure mass spectrometry (hpms).
